CARLOS ALBAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARLOS ALBAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARLOS ALBAN. CARLOS ALBAN is Senior Vice President in ABBOTT LABORATORIES ($ABT) and EVP, Commercial Operations in AbbVie Inc. ($ABBV) and Vice Chairman in AbbVie Inc. ($ABBV).
Latest Insider Trading Transactions of CARLOS ALBAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | M | 35.88 | 115,830 | 4,155,980 | 0 | |
Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 115,830 | 11,583,000 | 114,899 | 230.7 K to 114.9 K (-50.20 %) |
Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Buy | M | 35.88 | 115,830 | 4,155,980 | 230,729 | 114.9 K to 230.7 K (+100.81 %) |
Jul 08 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 23,000 | 2,300,000 | 114,899 | 137.9 K to 114.9 K (-16.68 %) |
Jul 08 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 30,325 | 3,032,555 | 137,899 | 168.2 K to 137.9 K (-18.03 %) |
Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | A | 93.50 | 114,566 | 10,711,921 | 114,566 | |
Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 10,125 | 0 | 200,316 | 190.2 K to 200.3 K (+5.32 %) |
Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 8,214 | 0 | 190,191 | 182 K to 190.2 K (+4.51 %) |
Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 14,340 | 0 | 181,977 | 167.6 K to 182 K (+8.55 %) |
Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 39,760 | 0 | 167,637 | 127.9 K to 167.6 K (+31.09 %) |
Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | A | 79.02 | 62,305 | 4,923,341 | 62,305 | |
Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 8,215 | 0 | 152,002 | 143.8 K to 152 K (+5.71 %) |
Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 14,340 | 0 | 143,787 | 129.4 K to 143.8 K (+11.08 %) |
Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 13,350 | 0 | 129,447 | 116.1 K to 129.4 K (+11.50 %) |
Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 18,545 | 0 | 116,097 | 97.6 K to 116.1 K (+19.01 %) |
Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 29.23 | 48,100 | 1,405,795 | 0 | |
Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 114.43 | 14,829 | 1,696,850 | 97,552 | 112.4 K to 97.6 K (-13.20 %) |
Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 114.63 | 46,997 | 5,387,463 | 112,381 | 159.4 K to 112.4 K (-29.49 %) |
Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 113.75 | 19,169 | 2,180,495 | 159,378 | 178.5 K to 159.4 K (-10.74 %) |
Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 29.23 | 48,100 | 1,405,795 | 178,547 | 130.4 K to 178.5 K (+36.87 %) |
Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 117.85 | 2,579 | 303,928 | 130,447 | 133 K to 130.4 K (-1.94 %) |
Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 118.26 | 25,976 | 3,071,922 | 133,026 | 159 K to 133 K (-16.34 %) |
Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 114.36 | 44,430 | 5,081,015 | 44,430 | |
Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 14,340 | 0 | 159,002 | 144.7 K to 159 K (+9.91 %) |
Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 16,567 | 0 | 144,662 | 128.1 K to 144.7 K (+12.93 %) |
Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 13,350 | 0 | 128,950 | 115.6 K to 129 K (+11.55 %) |
Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 24.21 | 45,800 | 1,108,736 | 0 | |
Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 70.00 | 45,800 | 3,206,000 | 114,745 | 160.5 K to 114.7 K (-28.53 %) |
Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 24.21 | 45,800 | 1,108,736 | 160,545 | 114.7 K to 160.5 K (+39.91 %) |
May 08 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 67.00 | 43,000 | 2,881,000 | 114,745 | 157.7 K to 114.7 K (-27.26 %) |
Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 61.36 | 95,750 | 5,875,220 | 95,750 | |
Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 13,350 | 0 | 192,466 | 179.1 K to 192.5 K (+7.45 %) |
Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 29,672 | 0 | 179,116 | 149.4 K to 179.1 K (+19.85 %) |
May 12 2016 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 63.52 | 47,438 | 3,013,262 | 149,444 | 196.9 K to 149.4 K (-24.09 %) |
Mar 02 2016 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 56.00 | 39,930 | 2,236,080 | 196,882 | 236.8 K to 196.9 K (-16.86 %) |
Feb 22 2016 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 54.86 | 79,870 | 4,381,668 | 79,870 | |
Mar 03 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 60.50 | 7,200 | 435,600 | 236,812 | 244 K to 236.8 K (-2.95 %) |
Mar 03 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 60.52 | 12,706 | 768,967 | 244,012 | 256.7 K to 244 K (-4.95 %) |
Feb 23 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 58.88 | 101,960 | 6,003,405 | 101,960 | |
Feb 23 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 51,580 | 0 | 256,718 | 205.1 K to 256.7 K (+25.14 %) |
Dec 04 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Gift | G | 0.00 | 40,442 | 0 | 40,442 | 0 to 40.4 K |
Dec 04 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 18,453 | 0 | 95,696 | 77.2 K to 95.7 K (+23.89 %) |
Dec 04 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Gift | G | 0.00 | 40,442 | 0 | 77,243 | 117.7 K to 77.2 K (-34.36 %) |
Oct 17 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 69.28 | 2,032 | 140,777 | 117,685 | 119.7 K to 117.7 K (-1.70 %) |
Oct 17 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 4,900 | 0 | 119,717 | 114.8 K to 119.7 K (+4.27 %) |
Sep 27 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 57.25 | 1,198 | 68,586 | 0 | |
Sep 27 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 70.00 | 1,198 | 83,860 | 114,817 | 116 K to 114.8 K (-1.03 %) |
Sep 27 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 57.25 | 1,198 | 68,586 | 116,015 | 114.8 K to 116 K (+1.04 %) |
Sep 21 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 56.98 | 1,918 | 109,288 | 0 | |
Sep 21 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 69.75 | 1,918 | 133,781 | 114,817 | 116.7 K to 114.8 K (-1.64 %) |
Sep 21 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 56.98 | 1,918 | 109,288 | 116,735 | 114.8 K to 116.7 K (+1.67 %) |
Sep 17 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 56.00 | 1,331 | 74,536 | 0 | |
Sep 17 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 68.75 | 1,331 | 91,506 | 114,817 | 116.1 K to 114.8 K (-1.15 %) |
Sep 17 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 56.00 | 1,331 | 74,536 | 116,148 | 114.8 K to 116.1 K (+1.16 %) |
Aug 01 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 66.62 | 352 | 23,451 | 114,817 | 115.2 K to 114.8 K (-0.31 %) |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 56.98 | 1,538 | 87,635 | 0 | |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 41.48 | 30,800 | 1,277,584 | 0 | |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 44.16 | 5,200 | 229,632 | 0 | |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 46.34 | 7,299 | 338,236 | 0 | |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 66.00 | 1,538 | 101,508 | 115,169 | 116.7 K to 115.2 K (-1.32 %) |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 65.00 | 43,299 | 2,814,435 | 116,707 | 160 K to 116.7 K (-27.06 %) |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 56.98 | 1,538 | 87,635 | 160,006 | 158.5 K to 160 K (+0.97 %) |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 41.48 | 30,800 | 1,277,584 | 158,468 | 127.7 K to 158.5 K (+24.13 %) |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 44.16 | 5,200 | 229,632 | 127,668 | 122.5 K to 127.7 K (+4.25 %) |
Jul 30 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 46.34 | 7,299 | 338,236 | 122,468 | 115.2 K to 122.5 K (+6.34 %) |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | A | 65.06 | 2,482 | 161,479 | 2,482 | |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 51.28 | 2,834 | 145,328 | 0 | |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 46.34 | 2,601 | 120,530 | 0 | |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 65.06 | 4,334 | 281,970 | 115,169 | 119.5 K to 115.2 K (-3.63 %) |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 51.28 | 2,834 | 145,328 | 119,503 | 116.7 K to 119.5 K (+2.43 %) |
Jul 25 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 46.34 | 2,601 | 120,530 | 116,669 | 114.1 K to 116.7 K (+2.28 %) |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 60.22 | 140 | 8,431 | 0 | 140 to 0 (-100.00 %) |
Mar 22 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 60.22 | 684 | 41,191 | 0 | 684 to 0 (-100.00 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 56.71 | 1,204 | 68,282 | 114,068 | 115.3 K to 114.1 K (-1.04 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 57.04 | 8,868 | 505,831 | 115,272 | 124.1 K to 115.3 K (-7.14 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 4,166 | 0 | 124,140 | 120 K to 124.1 K (+3.47 %) |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | A | 56.26 | 48,100 | 2,706,106 | 48,100 | |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 26,700 | 0 | 119,974 | 93.3 K to 120 K (+28.63 %) |
Dec 23 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 53.63 | 4,787 | 256,703 | 0 | |
Dec 23 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 55.00 | 4,787 | 263,285 | 93,274 | 98.1 K to 93.3 K (-4.88 %) |
Dec 23 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 53.63 | 4,787 | 256,703 | 98,061 | 93.3 K to 98.1 K (+5.13 %) |
Oct 18 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 52.73 | 2,032 | 107,147 | 93,274 | 95.3 K to 93.3 K (-2.13 %) |
Oct 18 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 4,900 | 0 | 95,306 | 90.4 K to 95.3 K (+5.42 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 48.00 | 2,100 | 100,800 | 90,406 | 92.5 K to 90.4 K (-2.27 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 47.99 | 700 | 33,594 | 92,506 | 93.2 K to 92.5 K (-0.75 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 47.99 | 5,883 | 282,349 | 93,206 | 99.1 K to 93.2 K (-5.94 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 48.01 | 810 | 38,888 | 99,089 | 99.9 K to 99.1 K (-0.81 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 47.64 | 5,374 | 256,017 | 99,899 | 105.3 K to 99.9 K (-5.10 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 7,000 | 0 | 105,273 | 98.3 K to 105.3 K (+7.12 %) |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | A | 46.60 | 45,800 | 2,134,280 | 45,800 | |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 32,500 | 0 | 98,273 | 65.8 K to 98.3 K (+49.41 %) |
Feb 03 2011 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 45.27 | 2,900 | 131,289 | 65,773 | 68.7 K to 65.8 K (-4.22 %) |
Oct 19 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 53.21 | 1,934 | 102,908 | 68,673 | 70.6 K to 68.7 K (-2.74 %) |
Oct 19 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 4,900 | 0 | 70,607 | 65.7 K to 70.6 K (+7.46 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 54.42 | 6,700 | 364,621 | 65,707 | 72.4 K to 65.7 K (-9.25 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 54.42 | 6,564 | 357,213 | 72,407 | 79 K to 72.4 K (-8.31 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 54.12 | 3,920 | 212,150 | 78,971 | 82.9 K to 79 K (-4.73 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 9,933 | 0 | 82,891 | 73 K to 82.9 K (+13.61 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | A | 54.50 | 34,600 | 1,885,700 | 34,600 | |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 21,000 | 0 | 72,958 | 52 K to 73 K (+40.42 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 23,600 | 0 | 51,958 | 28.4 K to 52 K (+83.22 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 53.94 | 1,200 | 64,730 | 28,358 | 29.6 K to 28.4 K (-4.06 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Payment of Exercise | F | 53.93 | 3,549 | 191,398 | 29,558 | 33.1 K to 29.6 K (-10.72 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Grant | A | 0.00 | 12,000 | 0 | 33,107 | 21.1 K to 33.1 K (+56.85 %) |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 51.28 | 1,001 | 51,331 | 0 | |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | M | 46.65 | 792 | 36,947 | 0 | |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 53.20 | 1,793 | 95,388 | 21,107 | 22.9 K to 21.1 K (-7.83 %) |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 51.28 | 1,001 | 51,331 | 22,900 | 21.9 K to 22.9 K (+4.57 %) |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Buy | M | 46.65 | 792 | 36,947 | 21,899 | 21.1 K to 21.9 K (+3.75 %) |
Nov 04 2009 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 50.93 | 100 | 5,093 | 21,107 | 21.2 K to 21.1 K (-0.47 %) |
Nov 04 2009 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 50.95 | 4,200 | 213,990 | 21,207 | 25.4 K to 21.2 K (-16.53 %) |
Nov 04 2009 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 50.97 | 300 | 15,291 | 25,407 | 25.7 K to 25.4 K (-1.17 %) |
Nov 04 2009 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Sell | S | 50.96 | 400 | 20,384 | 25,707 | 26.1 K to 25.7 K (-1.53 %) |
Oct 19 2009 | ABT | ABBOTT LABORATORIE ... | ALBAN CARLOS | Senior Vice Preside ... | Option Exercise | A | 51.68 | 21,000 | 1,085,280 | 21,000 |
Page: 1